TY - JOUR
T1 - History, Molecular Mechanisms, and Endoscopic Treatment of Barrett's Esophagus
AU - Spechler, Stuart Jon
AU - Fitzgerald, Rebecca C.
AU - Prasad, Ganapathy A.
AU - Wang, Kenneth K.
N1 - Funding Information:
Funding This work was supported by the Office of Medical Research , Department of Veterans Affairs and the National Institutes of Health ( R01-CA134571 ). Dr Spechler receives research support from AstraZeneca, Takeda Pharmaceuticals, Inc, and BARRX Medical, Inc. Dr Spechler is a consultant for Procter & Gamble and Xenoport. Dr Wang received NIH grants R01CA097048 , R01CA111603 , and R21CA122426 . In addition, Dr Wang receives research support from Mayo Foundation, BARRX Medical, Inc, Axcan Pharma, Olympus and Fujinon. Dr Prasad receives research support from AstraZeneca, Takeda, and the Mayo Foundation. Dr Fitzgerald receives research support from the Medical Research Council (MRC). Reviews in Basic and Clinical Gastroenterology
PY - 2010/3
Y1 - 2010/3
N2 - This report is an adjunct to the American Gastroenterological Association Institute's medical position statement and technical review on the management of Barrett's esophagus, which will be published in the near future. Those documents will consider a number of broad questions on the diagnosis, clinical features, and management of patients with Barrett's esophagus, and the reader is referred to the technical review for an in-depth discussion of those topics. In this report, we review historical, molecular, and endoscopic therapeutic aspects of Barrett's esophagus that are of interest to clinicians and researchers.
AB - This report is an adjunct to the American Gastroenterological Association Institute's medical position statement and technical review on the management of Barrett's esophagus, which will be published in the near future. Those documents will consider a number of broad questions on the diagnosis, clinical features, and management of patients with Barrett's esophagus, and the reader is referred to the technical review for an in-depth discussion of those topics. In this report, we review historical, molecular, and endoscopic therapeutic aspects of Barrett's esophagus that are of interest to clinicians and researchers.
KW - Esophageal Neoplasms
KW - Gastroesophageal Reflux
KW - Gene Expression Regulation
UR - http://www.scopus.com/inward/record.url?scp=77249090264&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77249090264&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2010.01.002
DO - 10.1053/j.gastro.2010.01.002
M3 - Review article
C2 - 20080098
AN - SCOPUS:77249090264
SN - 0016-5085
VL - 138
SP - 854
EP - 869
JO - Gastroenterology
JF - Gastroenterology
IS - 3
ER -